3 -5 (43) 2022 — Dr. Imran Aslam, Ibragimova E.F. — ACUTE MYOCARDITIS ASSOCIATED WITH COVID19 VACCINATION

ACUTE MYOCARDITIS ASSOCIATED WITH COVID19 VACCINATION

Dr. Imran Aslam, Samarkand State Medical university, Samarkand, Uzbekistan

Ibragimova E.F., Samarkand State Medical university, Samarkand, Uzbekistan

Abdurakhmanova Z.E., Samarkand State Medical university, Samarkand, Uzbekistan

Arslonova R.R. Samarkand State Medical university, Samarkand, Uzbekistan

Resume

When it comes to myocarditis, the term encompasses a wide range of immunological processes that can have an impact on the function and/or structure of the heart. Infections with viruses are responsible for the majority of myocarditis cases. The presence of non-infectious causes of myocarditis is rare, however it has been associated to systemic inflammatory illnesses, medicines, and vaccines in some cases. Minor side effects are typical following the illness (COVID-19) vaccine, and they may become more severe with the second dosage. However, more substantial adverse properties have been documented following the disease (COVID-19) vaccine. Troponin levels were found to be high in the lab, while viral serologists found no evidence of infection. Although our findings are contradictory, it appears that COVID-19 infection is associated with a much higher risk of cardiac involvement than COVID-19 immunization in this study.

Keywords: Myocarditis, Acute myocarditis, Cardiac magnetic resonance COVID-19 vaccinationmRNA-COVID-19 vaccine

First page

13

Last page

18

For citation: Dr. Imran Aslam, Ibragimova E.F., Abdurakhmanova Z.E., Arslonova R.R. ACUTE MYOCARDITIS ASSOCIATED WITH COVID19 VACCINATION //New Day in Medicine 5(43)2022 13-18 https://clck.ru/hEeU3

LIST OF REFERENCES:

  1. Aye Y.N., Mai A.S., Zhang A., Lim O.Z. H., Lin N., Ng C.H., … Chew N.W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. //QJM: An International Journal of Medicine.
  2. Sulemankhil I., Abdelrahman M., Negi S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine.
  3. Lee A.S., Iswaree D.D., Balakrishnan O., Khoo C.Y., Ng C.T., Loh J.K., … & Sim D.K. (2022). Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020–October 2021). Heart, Lung and Circulation.
  4. Woo W., Kim A.Y., Yon D.K., Lee S.W., Hwang J., Jacob L., … & Smith L. (2022). Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID‐19 vaccine. Journal of medical virology, 94(4), 1566-1580.
  5. Das B.B., Moskowitz W.B., Taylor M.B., & Palmer A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607.
  6. Habib M.B., Hamamyh T., Elyas A., Altermanini M., & Elhassan M. (2021). Acute myocarditis following administration of BNT162b2 vaccine. IDCases, 25, e01197.
  7. Biswas N., Mustapha T., Khubchandani J., & Price J. H. (2021). The nature and extent of COVID-19 vaccination hesitancy in healthcare workers. Journal of community health, 46(6), 1244-1251.
  8. Arnold J., Winthrop K., & Emery P. (2021). COVID-19 vaccination and antirheumatic therapy. Rheumatology, 60(8), 3496-3502.
  9. Khubchandani J., Sharma S., Price J.H., Wiblishauser M.J., Sharma M., & Webb F.J. (2021). COVID-19 vaccination hesitancy in the United States: a rapid national assessment. Journal of Community Health, 46(2), 270-277.
  10. Dye C., & Mills M.C. (2021). COVID-19 vaccination passports. Science, 371(6535), 1184-1184.
  11. Wang J., Jing R., Lai X., Zhang H., Lyu Y., Knoll M. D., & Fang H. (2020). Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines, 8(3), 482.
  12. Dodd R.H., Pickles K., Nickel B., Cvejic E., Ayre J., Batcup C., … & McCaffery K. J. (2021). Concerns and motivations about COVID-19 vaccination. The Lancet Infectious Diseases, 21(2), 161-163.
  13. Washington T., Bryan R., & Clemow C. (2021). Adenopathy following COVID-19 vaccination. Radiology, 299(3), E280-E281.
  14. Мусаева Д. М., et al. “Антибиотики.” (2019).
  15. Мусаева Д. М., Раджабов Н. Г. Перспективы изучения применения препарата кверцетина для профилактики COVID-19 у медицинских работников. – 2020.
  16. Oblokulov A. R., Musaeva D. M., Elmuradova A. A. Clinical and epidemiological characteristics of the new coronavirus infection (COVID-19) //New day in medicine. – 2020. – №. 2. – С. 30.
  17. Inoyatov A.SH., Ikhtiyarova G.A., Musaeva D.M., Karimova G.K., Assessment of the status of pregnant women with diabetes mellitus infected with covid-19 //New Day in Medicine 2(30)2020 101-103 https://cutt.ly/gcQcYPa

file

download